Baptiste D.
- Country
- France
- Department
- Hematology
Research Overview
- Phase 3 Randomized Double‑Blind Trial of Orelabrutinib Combined with Rituximab and Bendamustine versus Rituximab‑Bendamustine in Treatment‑Naïve Mantle Cell Lymphoma
- Comparative Efficacy of Amoxicillin-Clavulanic Acid Versus Amoxicillin-Clavulanic Acid Plus Ciprofloxacin in Chemotherapy-Induced Fever in Adult Hematology Patients
- Evaluation of 18F-Fludarabine PET in Initial and Relapsed Assessment of Symptomatic Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 3 of 60 partner sites.
Specializations
Hematologic Oncology
The investigator specializes in the study and treatment of multiple myeloma, focusing on innovative diagnostic and therapeutic approaches in hematologic malignancies.
- Multiple Myeloma Management
- Blood Cancer Diagnostics
- Plasma Cell Disorders
Current research activities center on advanced imaging techniques for disease assessment and treatment monitoring.
Medical Imaging
Expertise in advanced PET imaging technologies for hematologic malignancies, with particular emphasis on novel radiotracer applications in cancer detection.
- PET Imaging Applications
- Molecular Imaging
- Disease Assessment Techniques
Focuses on developing and validating innovative imaging approaches for accurate disease evaluation.
Treatment Response Assessment
Specializes in evaluating therapeutic response in hematologic conditions through advanced imaging methodologies.
- Response Monitoring
- Disease Progression Assessment
- Treatment Effectiveness Evaluation
Investigates innovative approaches for tracking disease status and treatment outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.